Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CQSS2 System vs NicoDerm CQ Patch for Smoking Cessation
NCT03178422Phase 2Completed
- Sponsor
- Chrono Therapeutics
- Start
- Aug 2017
- Primary completion
- Oct 2017
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotine patch in nicotine dependence, sponsored by Chrono Therapeutics. Started Aug 2017; status: completed.
02
Drugs
nicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT03178422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03178422.